NCT04058743

Brief Summary

The purpose of this study is to compare clinical outcomes of patients with self reported nickel sensitivity undergoing primary total knee arthroplasty (TKA) with conventional, standard-of-care vs nickel-free implants. The hypothesis is that patients with a self-reported nickel sensitivity will have similar patient reported outcome scores compared to those patients without reported nickel sensitivity. Therefor the anticipation is for there to be no differences in other clinical outcome measures or functional outcome scores between the two cohorts.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 15, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

September 27, 2019

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 11, 2024

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 21, 2024

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

May 1, 2026

Completed
Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

5.2 years

First QC Date

August 14, 2019

Results QC Date

January 11, 2026

Last Update Submit

April 29, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Knee Society Score (KSS)

    Change from pre operative to post operative Knee Society Scores at various time intervals. KSS is scored 0-100 with 100 being a perfectly functioning knee and is used as a gauge of success for a knee replacement.

    3 weeks

Secondary Outcomes (5)

  • Number of Participants With Complications

    90 days

  • Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS, JR.)

    3 weeks

  • Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS, JR.)

    6 weeks

  • Number of Participants With Proper Component Alignment and *Without* Any Signs of Loosening

    3 weeks after surgery

  • Number of Participants With Proper Component Alignment and *Without* Any Signs of Loosening

    6 weeks after surgery

Study Arms (2)

TKA with standard cobalt chromium components

ACTIVE COMPARATOR

Patients randomized to this group will receive the standard cobalt chromium components in their total knee arthroplasty

Device: TKA with standard cobalt chromium components

TKA with nickel free components

EXPERIMENTAL

Patients randomized to this group will receive nickel free components in their total knee arthroplasty

Device: TKA with nickel free components

Interventions

Patients will be randomized to receive either the standard cobalt chromium components or nickel free components

TKA with nickel free components

Patients will be randomized to receive either the standard cobalt chromium components or nickel free components

TKA with standard cobalt chromium components

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing primary TKA for the diagnosis of osteoarthritis or inflammatory arthritis with self-reported nickel allergy. Patients are routinely asked about nickel sensitivity as a part of the standard pre operative questionnaire already in place.

You may not qualify if:

  • Patients less than 18 years of age
  • Patients undergoing revision TKA
  • Non english speaking patients
  • Patient who have medical comorbidities that prevent elective TKA

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rush University medical Center

Chicago, Illinois, 60612, United States

Location

MeSH Terms

Conditions

Hypersensitivity

Condition Hierarchy (Ancestors)

Immune System Diseases

Results Point of Contact

Title
Anne DeBenedetti, MSc
Organization
Rush University Medical Center

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Patients will be blinded to the type of implant that they receive.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Prospective randomized controlled trial with two groups: Total knee replacement with standard cobalt chromium components vs Total Knee Replacements with nickel free components.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Orthopaedic Surgery

Study Record Dates

First Submitted

August 14, 2019

First Posted

August 15, 2019

Study Start

September 27, 2019

Primary Completion

December 11, 2024

Study Completion

December 21, 2024

Last Updated

May 1, 2026

Results First Posted

May 1, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations